id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2008-N-0424-0024,FDA,FDA-2008-N-0424,"Immediately in Effect Guidance for Industry; Compliance Policy for
Combination Product Postmarketing Safety Reporting; Availability",Notice,Notice of Availability,2018-03-21T04:00:00Z,2018,3,2018-03-21T04:00:00Z,,2019-07-23T11:13:53Z,2018-05688,0,0,0900006483035dd7
FDA-2008-N-0424-0025,FDA,FDA-2008-N-0424,Compliance Policy for Combination Product Postmarketing Safety Reporting Immediately in Effect Guidance for Industry and Food and Drug Administration Staff,Other,Guidance,2018-03-21T04:00:00Z,2018,3,2018-03-21T04:00:00Z,,2024-11-07T01:24:51Z,,1,0,09000064830371ce
FDA-2008-N-0424-0023,FDA,FDA-2008-N-0424,Postmarketing Safety Reporting for Combination Products Guidance for Industry and FDA Staff DRAFT GUIDANCE,Other,Guidance,2018-03-21T04:00:00Z,2018,3,2018-03-21T04:00:00Z,2018-06-20T03:59:59Z,2019-10-23T14:45:31Z,,0,0,090000648302e3eb
FDA-2008-N-0424-0022,FDA,FDA-2008-N-0424,Postmarketing Safety Reporting for Combination Products; Draft Guidance for Industry and Food and Drug Administration Staff; Availability,Proposed Rule,GDL Guidance,2018-03-21T04:00:00Z,2018,3,2018-03-21T04:00:00Z,2018-06-20T03:59:59Z,2018-03-21T13:13:54Z,2018-05687,0,0,09000064830356f0